Search
liver (function) tests (LFT, liver panel, hepatic function panel)
Indications:
- evaluation of liver disease
Clinical significance:
1) elevations in serum transaminases (serum AST & serum ALT)
a) increases in serum transaminases > 5X upper limit of normal indicate hepatic dysfunction
b) serum gamma-glutamyltransferase (GGT) will also be elevated with hepatic dysfunction, but is also elevated with cholestasis
c) AST/ALT ratio < 1 with most elevations of serum transaminases secondary to hepatic dysfunction
- ALT is a more liver-specific enzyme than AST
d) non-alcoholic fatty liver is the most common cause [3]
- morbid obesity may cause steatohepatitis
e) alcohol-induced hepatitis:
- AST/ALT ratio generally > 2
f) viral hepatitis
g) toxin-induced hepatitis
h) drug-induced hepatitis
i) hemochromatosis:
- transaminases generally moderately elevated
- ferritin levels are very high
j) autoimmune hepatitis
- primarily affects women 20-40 years of age
- transaminases generally quite elevated
k) Wilson's disease
- patients < 40 years of age
- eye findings: Kayser-Fleischer ring
- neurologic symptoms may be present
l) alpha-1 antitrypsin deficiency
- may have associated COPD
2) elevations in serum alkaline phosphatase (ALP)
a) ALP > 3X upper limit of normal suggests cholestasis or biliary tract disease
b) serum AST & serum ALT are generally < 3X upper limit of normal in the absence of hepatic dysfunction
c) serum gamma-glutamyl transferase (GGT) is also elevated with cholestasis or biliary tract disease
d) kidney, bone & placenta are other sources of alkaline phosphatase
e) biliary tract obstruction
- choledocholithiasis
- biliary stricture
- pancreatic carcinoma
- neoplasm in region of ampulla of Vater
- pancreatitis
- biliary atresia
f) drug-induced cholestasis
g) right-sided heart failure
h) cholestasis of pregnancy
i) hemolytic anemias
j) disorders of ineffective erythropoiesis
- thalassemia
k) hepatobiliary neoplasms
- primary benign & malignant tumors
- metastatic tumors
l) primary biliary cirrhosis
- middle-aged women
- very elevated alkaline phosphatase
m) primary sclerosing cholangitis
- most common in young to middle-aged men
- generally associated with ulcerative colitis
Management:
- patients with abnormal liver function tests should be screened for:
a) viral hepatitis
b) hemochromatosis [3]
c) Wilson's disease (young patients)
Notes:
- recommend inclusion of serum cholesterol (marker of hepatic synthetic capacity)
Related
cholestasis
drugs that may affect liver function tests (LFTs)
elevated serum transaminases; transaminitis; abnormal liver function tests
hepatitis
liver (function) tests (LFT, liver panel, hepatic function panel)
Specific
alanine aminotransferase (ALT) in serum/plasma (SGPT)
alkaline phosphatase (ALP) in serum/plasma
aspartate aminotransferase (AST) in serum (SGOT)
bilirubin (conjugated/unconjugated) in serum
cholesterol in serum/plasma
gamma-glutamyltransferase (GGT) in serum
hepatitis C virus (HCV) FibroSURE
prothrombin time (PT)
General
chemistry panel
References
- Prescriber's Letter 11(9): 2004
Detail-Document#: 200903
(subscription needed) http://www.prescribersletter.com
- Prescriber's Letter 12(12): 2005
Liver function test scheduling
Detail-Document#: 211210
(subscription needed) http://www.prescribersletter.com
- Medical Knowledge Self Assessment Program (MKSAP) 15, 17.
American College of Physicians, Philadelphia 2009, 2015
- Prescriber's Letter 17(17): 2010
Liver function test scheduling
Detail-Document#: 260704
(subscription needed) http://www.prescribersletter.com
- Henry's Clinical Diagnosis & Management by Laboratory Methods,
21st edition, McPherson RA & Pincus MR (es), W.B. Saunders Co.,
Philadelphia, PA. 2007
- Green RM, Flamm S.
AGA technical review on the evaluation of liver chemistry tests.
Gastroenterology. 2002 Oct;123(4):1367-84.
PMID: 12360498
- Pratt DS, Kaplan MM.
Evaluation of abnormal liver-enzyme results in asymptomatic patients.
N Engl J Med 2000 Apr 27; 342:1266
PMID: 10781624
https://www.nejm.org/doi/full/10.1056/NEJM200004273421707
- Kwo PY, Cohen SM, Lim JK.
ACG clinical guideline: evaluation of abnormal liver chemistries.
Am J Gastroenterol. 2017;112:18-35.
PMID: 27995906
Components
alanine aminotransferase (ALT) in serum/plasma (SGPT)
alkaline phosphatase (ALP) in serum/plasma
aspartate aminotransferase (AST) in serum (SGOT)
bilirubin (total) in serum/plasma (TBIL)
bilirubin conjugated in serum
gamma-glutamyltransferase (GGT) in serum
protein (total) in serum
prothrombin time (PT)